Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION

Ia. Forces Shaping the Emerging Bioeconomy
in Agriculture

Global agriculture is at a defining moment.  Society looks to policy makers and leadership groups in agriculture to develop solutions for world hunger, biofuels, drought and management of water resources, zoonotic and pandemic diseases, scarce land resources and a safe food supply.  Agriculture is in a key position to provide these solutions as long as technology is adopted and optimally used.  During this session, you will hear some of the leaders in Agribusiness speak on how they are positioning their organizations for winning solutions and strategies to meet these challenges.


 



Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION

Ic.
The Next Generation of Georgia’s
Life Science Companies

Georgia is home to some of the leading young companies in the life science industry. This session will feature presentations by some of our most innovative emerging companies. This group of companies provides a window into the future of the life science industry in Georgia and the Southeast.
 









TUESDAY, SEPTEMBER 23, 2008
 

Chairman’s reception (by invitation only)

WEDNESDAY, SEPTEMBER 24, 2008

 

Badge Pickup
Georgia World Congress Center
Building B

 

Welcome and Introduction of Mayor Franklin
Thomas H. Callaway, MD; President, Life Science Partner and Managing Director, Georgia Venture Partners

 

Welcome
The Honorable Shirley Franklin; Mayor, City of Atlanta

 

Plenary Presentations
James C. Greenwood; President and Chief Executive Officer, Biotechnology Industry Organization

 

Tanja Popovic, MD, PhD; Chief Science Officer, U.S. Centers for Disease Control and Prevention

 

Stephen A. Hill, BM, BCh, MA, FRCS; President and Chief Executive Officer,
Solvay Pharmaceuticals


  The Honorable Louis W. Sullivan, MD; President Emeritus, Morehouse School of Medicine

 

Student Business Plan Competition
Robert T. McNally, PhD; President and Chief Executive Officer, GeoVax

  Exhibition and Scientific Poster Viewing

 

MORNING CONCURRENT FOCUS SESSION
(Click on the title of each session for its description)

Ia. Forces Shaping the Emerging Bioeconomy in Agriculture


Clifton A. Baile, PhD; Moderator, Georgia Research Alliance Eminent Scholar in Agricultural Biotechnology and Distinguished Professor of Animal Science and Foods and Nutrition,
University of Georgia

   

Gregg W. BeVier, DVM, MBA; Moderator, Chief Executive officer, AgGlobalVision

  Dennis T. Avery; Senior Fellow of the Hudson Institute and Director of its Center for Global Food Issues


Joseph C. Moran; Senior Division Vice President Fresh Foodservice Division, Pilgrim’s Pride Corporation



Michael C. Robach; Vice President, Corporate Food Safety & Regulatory Affairs, Cargill, Incorporated

Ib. Traversing the Regulatory & Clinical Compliance Maze: From Preclinical to Market Approval
  David W. Mullis, Jr., PhD, RAC; Moderator, Mullis & Associates

Stephanie E. Hubbard; Bioresearch Monitoring Specialist, Food and Drug Administration

Alan G. Minsk; Partner and Chair of the Food & Drug Practice Team,
Arnall Golden Gregory LLP

Mamta Trivedi; Global Senior Director, QLAB, Global Quality Assurance, Central Labs, Quintiles Transnational Corp.

Ic. The Next Generation of Georgia’s Life Science Companies

H. Lee Herron, DVM; Moderator, Vice President of Commercialization,
Georgia Research Alliance

Id. Cardiovascular Innovation in Public-Private Partnerships
   

Jay S. Yadav, MD; Moderator, Chairman and Chief Executive Officer, CardioMEMS

 
Todd T. Sherer, PhD; Moderator, Associate Vice President for Research and Director,
Office of Technology Transfer, Emory University
    Nic Chronos, MD; Chief Medical and Scientific Officer, Saint Joseph’s Translational
Research Institute
    Omar M. Lattouf, MD, PhD, FACS,FACC; Associate Professor of Surgery / Cardiothoracic, Emory University. Inventor, Founder and Principal of TransCardiac Therapeutics, Inc.
    Michele M. Molden; President and Chief Executive Officer, Piedmont Heart Institute
 
David L. West, PhD, MPH; Vice President, Medical Device Development, Quintiles Consulting

  Lunch

  Research Advances in Georgia: Neuroscience



Georgia Life Sciences Summit 2008

Research Advances in Georgia: Neuroscience
Neuroscience is one of the strongest areas of interdisiciplinary and inter-institutional research in Georgia.  This research is pushing the envelope on one of science's last and most daunting frontiers — the brain. This work holds great promise for understanding basic brain function and treating illnesses such as Alzheimer's disease and post traumatic stress disorder.  The Center for Behavioral Neuroscience will host this plenary session where speakers will discuss recent advances in neuroscience research from the laboratories of scientists at Georgia’s research universities.
 
 
H. Elliott Albers, PhD; Moderator, Regents Professor, Georgia State University, Director, Center for Behavioral Neuroscience
    Dennis W. Choi, MD, PhD; Executive Director, Professor of Neurology, Pharmacology, and Biology, Emory University
 

 

Stephen P. DeWeerth, PhD; Professor and Associate Chair for Graduate Studies Wallace H. Coulter Department of Biomedical Engineering School of Electrical and Computer Engineering, Georgia Tech/Emory University
    Gaylen L. Edwards, DVM, PhD; Professor and Department Head, Department of Physiology and Pharmacology College of Veterinary Medicine, The University of Georgia
    Peter R. MacLeish, PhD; Director Neuroscience Institute, Morehouse School of Medicine
    Walt Wilczynski, PhD; Professor of Psychology, Director, Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University
 



Robert K. Yu, PhD, MedScD; Professor and Director, Institute of Molecular Medicine & Genetics, Medical College of Georgia

  Student Business Plan Competition
Robert T. McNally, PhD; President and Chief Executive Officer, GeoVax

 

Exhibition and Scientific Poster Viewing

  Afternoon Concurrent Focus Session
(Click on the title of each session for its description)

IIa.

Medical Devices in Georgia
presented in partnership with the Southeast Medical Device Association
   

John G. Edwards; Moderator, Chief Executive Officer, Apeliotus Technologies

   

Why Medical Devices are Hot

   

Keith Barritt; Prinicpal, Fish & Richardson PC

   

Ted Davis; Vice President, Business Development, Wright Medical Group

   

Al Lauritano; Director, Business Development, BD Technologies

   

Georgia Makes its Mark in Medical Devices

   

Mark J. Phelps, PhD.; Senior Vice President of Research and Development,
LIFESYNC Incorporated

   

Brian Walsh; President, Dornier MedTech America

   

Lynn Winterton; Global Head of Research, CIBA Vision

IIb.

“Delivering the Golden Egg” - IPOs, M&A and Partnering in the Life Sciences Industry
    Howard D. Palefsky; Moderator, General Partner/Managing Member Montreux Equity Partners
    Steven P. Damon; Vice President, Business Development, Altea Therapeutics
   

Randy Guggenheimer; Managing Director, Burrill & Company

   

Bruce C. Robertson, PhD; Managing Director, H.I.G. Ventures

    John W. Sharkey, PhD; Vice President, Business Development, Sciele Pharma, Inc

IIc. Bioenergy: A Fuel for Success

   

Jill Stuckey; Moderator, Director, Georgia Energy Innovation Center

    Nathan McClure; Moderator, Director of Fore



Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION

IIb. “Delivering the Golden Egg” - IPOs, M&A and Partnering in the Life Sciences Industry


Investors put money into emerging life science companies expecting to profitably take money out later.  This “exit” ordinarily takes the form of either going public or being acquired by a larger company.  What is the current status of IPOs and M&A in the industry?  And how does partnering affect the eventual exit for a company?  Our panel of industry experts will provide up-to-date insights.
 
st Energy and Development,
Georgia Forestry Commission
   

James Fang, PhD; Director of Engineering, Sriya Innovations, Inc.

    Joy Doran Peterson, PhD; Assistant Professor of Microbiology,
The University of Georgia
    Bill Schafer; Senior Vice President of Business Development, Range Fuels, Inc.

IId.
Why Georgia?:  The Ascent and Maturation of Georgia's Talent Pool and Biotech Labor Market presented by The GaBio Emerging Leaders Network
   

Blaine W. Lindsey; Moderator, Attorney at Law, Representative, GaBio Emerging Leaders Network

    Mark Banks; Vice President of Human Resources, Sciele Pharma, Inc
   

Amanda DePalma; Director, Global Strategic Marketing, Kimberly-Clark Health Care

    Jeffrey M. Humphreys; Director, Selig Center, Terry College of Business,
The University of Georgia

 

Keynote Address
The Honorable Sonny Perdue, DVM;
Governor, State of Georgia (invited)

 

Georgia Bio Honors Senator Bob Dole for His Contribution to University-based Innovation
Senator Bob Dole; Special Counsel, Alston & Bird

  28 Years of Impact: The Bayh-Dole Act Accelerated the Realization of Georgia’s Biotechnology Economy
 

C. Michael Cassidy; President and Chief Executive Officer, Georgia Research Alliance

  James C. Greenwood; President and Chief Executive Officer, Biotechnology Industry Organization

 

Concluding Comments
Senator Bob Dole; Special Counsel, Alston & Bird

 

Announcement of Poster Winners

  Anthony J. Shuker, PhD; Moderator
  David Wynes, PhD; Moderator, Vice President for Research Administration,
Emory University

 

Closing Remarks
Thomas H. Callaway, MD; President, Life Science Partner and Managing Director, Georgia Venture Partners

 

Gala Party
Georgia World Congress Center
Building A: Rooms 311-314

   
   
   
   
   









Copyright 2008 Informed Horizons, LLC
All rights reserved. Additional copyright information also applies.



Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION

IId. Why Georgia?:  The Ascent and Maturation of Georgia's Talent Pool and Biotech Labor Market presented by The GaBio Emerging Leaders Network

The first question a biotech business asks before locating in a certain region is often:  "Is there a large, educated, and specialized workforce in place to support our firm?"  Likewise, the first question a young biotech professional asks when choosing a market is:  "Is there sufficient opportunity for advancement towards a meaningful career?"  For the first time, the answer to both of those questions in Georgia is an unequivocal "Yes!"  In this session, leading economic experts will discuss Georgia's human resources economics, and some of the region's leading companies will discuss the arrival of Georgia as a mature hotbed of talent competitive with any other U.S. market.
 



Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION

IIc.
Bioenergy: A Fuel for Success
As oil prices continue to rise and concerns of greenhouse gas emissions become more serious, Georgia pine pine forests are poised to provide relief for these energy and environmental concerns.  Georgia is uniquely positioned to be a leader in the production of pine biomass and commercializing a cellulosic fuels industry.  Speakers will discuss the latest advances in technology, status of the developing industry, and the benefits to our region.
 



Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION

IIa. Medical Devices in Georgia

“Why Medical Devices are Hot” – This segment will explore some of the reasons that medical devices are strong in today’s market, including attractive investment/return dynamics, strong options for exits, and recent Supreme Court decisions (Riegel v. Medtronic, Warner-Lambert v. Kent) that shield FDA approved medical devices from liability claims at the state level.

"Georgia Makes its Mark in Medical Devices” – This segment will present three Georgia medical device company success stories.
 



Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION

Id.
Cardiovascular Innovation in Public-Private Partnerships
Cardiovascular disease remains the nation’s number one health care problem and Georgia has some of the highest rates in the country for heart disease, stroke and hypertension.  There is a need not only for new technologies for cardiovascular disease but also for new delivery and business models that can function in the rapidly changing and increasingly challenging regulatory and reimbursement environment.  Atlanta doctors, institutions, and universities have been at the forefront of both technological and programmatic solutions.  This panel will bring together some of these key innovators in cardiology and cardiac surgery as well as administrators from the region’s leading cardiovascular institutions to discuss these challenges.  Issues and challenges surrounding the use of public/private partnerships to bring new products to market will also be addressed.
 



Georgia Life Sciences Summit 2008
CONCURRENT FOCUS SESSION

Ib. Traversing the Regulatory & Clinical Compliance Maze: From Preclinical to Market Approval


The focus of this breakout session is to address 1) Working/Communicating Effectively with FDA; 2) Overview of Regulatory Submissions; and 3) Clinical Trials--Common Pitfalls & Challenges.